Zytomics is a manufacturer of products, solutions and systems for clinical cancer diagnostics. It covers the tissue-based diagnostic workflow for pathology and cytogenetics labs, from reagents and stain automation to digital imaging and analysis.
The portfolio includes in-situ hybridisation (ISH), immunohistochemistry (IHC) and microarray products, plus imaging and analysis solutions. The goal is to give pathologists the products and expertise they need for a precise and reliable cancer diagnosis.
Zytomics is hiring a VP HR to own the global HR agenda. Reporting directly into the CEO, this person will support organic growth in the country entities, lead HR in acquisitions and integrations, shape the organisation and build an HR infrastructure that is ready for investor and due diligence requests at any time. This is a newly created role in the organization.

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner.
Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.